Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei(Boston Children's Hospital), Daniel J. Siegwart(Southwestern Medical Center)
Cited by 575
Related Papers
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
|Nature Materials|2021|611
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery
|Nature Protocols|2022|499
Getting Drugs Across Biological Barriers
|Advanced Materials|2017|237
Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes
|Journal of the American Chemical Society|2021|161
A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
|Angewandte Chemie International Edition|2020|130